Page last updated: 2024-11-05

1,1,1-trichloroethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trichloroethanes: Chlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,1,1-trichloroethane : A member of the class of chloroethanes carrying three chloro substituents at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6278
CHEMBL ID16080
CHEBI ID36015
SCHEMBL ID458743
SCHEMBL ID16434
MeSH IDM0082939

Synonyms (136)

Synonym
1,1,1-trichloraethan
1,1,1-trichlorethane
trichloro-1,1,1-ethane
CHEBI:36015 ,
alpha-t
1,1,1-tce
alpha-trichloroethane
methyl chloroform
1,1,1-trichloroethane, technical grade
1,1-trichloroethane
.alpha.-t
1,1-trichloraethan
chloroethene nu
methyltrichloromethane
trichloro-1,1-ethane
aerothene tt
chlorothene nu
chlorten
nsc9367
chlorothene vg
solvent 111
chlorothene, inhibited
trichloroethane
wln: gxgg1
.alpha.-trichloroethane
chlorothane nu
1,1 trichloroethane
1,1-tricloroetano
1,1-trichloorethaan
chlorothene
71-55-6
nci-c04626
nsc-9367
methylchloroform
chlorotene
chloroform, methyl-
inhibisol
inchi=1/c2h3cl3/c1-2(3,4)5/h1h
ethane, 1,1,1-trichloro-
1,1,1-trichloroethane
NCGC00091158-01
tafclean
hcc 140a
ai3-02061
baltana
dowclene ls
ici-cf 2
trichloro-1,1,1-ethane [french]
three one a
genklene lb
three one s
rcra waste number u226
cleanite
ethana nu
einecs 200-756-3
f 140a
rcra waste no. u226
un 2831
un2831
trichloromethylmethane
hsdb 157
epa pesticide chemical code 081201
1,1,1-tricloroetano [italian]
tri-ethane
1,1,1-trichloraethan [german]
chlorothene sm
nsc 9367
caswell no. 875
1,1,1-trichloroethane [un2831] [poison]
trichloroethane, 1,1,1-
ccris 1290
brn 1731614
cf 2
NCGC00091158-02
un-2831
rcra-u226
CHEMBL16080
trichloroethanes
1,1,1-trichloro-ethane
C18246
1,1,1-tris(chloranyl)ethane
A837242
NCGC00260667-01
dtxsid0021381 ,
cas-71-55-6
dtxcid501381
tox21_203122
25323-89-1
4-01-00-00138 (beilstein handbook reference)
113c650ir1 ,
unii-113c650ir1
ec 200-756-3
1,1,1-tricloroetano
FT-0605938
FT-0605984
1,1,1-trichloroethane [usp-rs]
trichloroethane [inci]
1,1,1 trichloroethane [vandf]
trichloroethane [ii]
1,1,1-trichloroethane [mi]
1,1,1 trichloroethane
1,1,1-trichloroethane [iarc]
methylchloroform [hsdb]
trichloroethane [mart.]
trichloroethane [vandf]
AKOS015899823
1-1-1-trichloroethane
gtpl5482
SCHEMBL458743
SCHEMBL16434
solvethane
distillex ds1
ethana
ch3ccl3
chloroetene
90229-85-9
1,1,1-trichloroethane-2-d1
1,1,1-trichloroethan
1,1,1-trichloroethane, 97%
1,1,1-trichloroethane 100 microg/ml in methanol
1,1,1-trichloroethane 10 microg/ml in methanol
trichloroethane (van)
1,1, 1-tricloroetano (italian)
methyl-chloroform
1,1,1-trichlorathan
1,1, 1-trichloraethan (german)
1,1,1-trichloorethaan (dutch)
trichloro-1,1, 1-ethane (french)
1,1,1-trichloroethane (acd/name 4.0)
1,1,1-trichloroethane 1000 microg/ml in methanol
Q161268
1,1,1-trichloroethane (2,2,2-d3)
19b - chlorinated solvents
6 - vocs
2e - residual solvents
07b - chlorinated solvents

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Related compounds such as halothane may have a toxic interaction after exposure to trichloroethane."( Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane.
Hugh-Jones, P; Jackson, G; Marjot, R; McLeod, AA; Monaghan, MJ, 1987
)
0.53
" There were no toxic effects noted in male or female mice at any exposure concentration tested."( 1,1,1-trichloroethane formulation: a chronic inhalation toxicity and oncogenicity study in Fischer 344 rats and B6c3F1 mice.
Calhoun, LL; Frauson, LE; Quast, JF, 1988
)
1.72
" The results obtained are sufficiently reproducible to yield an order of cytotoxicity: hexachlorobutadiene is about 100-fold more toxic than chloroform or 1,2-dichloroethane; whereas, 1,1,1-trichloroethane is 10-fold more toxic than these two compounds."( [A study of the cytotoxicity of chloroform, 1-2-dichloroethane, 1,1,1-trichloroethane and hexachlorobutadiene to mouse L cells (author's transl)].
Chau, N; Elias, Z; Hartemann, P, 1981
)
0.69
" There was evidence of slight hepatocytotoxicity at 10 g/kg, but no progression of injury nor appearance of adverse effects were seen during acute or short-term exposure."( Acute, short-term, and subchronic oral toxicity of 1,1,1-trichloroethane in rats.
Acosta, D; Bruckner, JV; Kyle, GM; Luthra, R; Mehta, SM; Muralidhara, S; Sethuraman, S, 2001
)
0.56
" Other short-term and subchronic inhalation exposures confirmed acute and short-term exposure findings that the toxic effects of inhalation were a function of both concentration and time."( Final report on the safety assessment of Trichloroethane.
, 2008
)
0.35

Pharmacokinetics

A unified physiologically based pharmacokinetic (PB-PK) model was developed and used to describe the disposition of 1,1,1-trichloroethane in rats, mice, and humans. The PB-PK model was used to derive predicted safe concentrations of noncarcinogens in drinking water for humans based on experimentally determined no observed adverse effect levels.

ExcerptReferenceRelevance
"The present study evaluates the sensitivity of pharmacokinetic model output to variability in the biochemical and metabolic input parameters."( Sensitivity analysis for physiologically based pharmacokinetic models.
Hetrick, DM; Jarabek, AM; Travis, CC, 1991
)
0.28
"A methodology for using physiologically based pharmacokinetic (PBPK) models to derive predicted safe concentrations of noncarcinogens in drinking water for humans based on experimentally determined no observed adverse effect levels (NOAELs) in animals is presented and applied to the case of 1,1,1-trichloroethane (methyl chloroform, MC)."( Pharmacokinetics for regulatory risk analysis: the case of 1,1,1-trichloroethane (methyl chloroform).
Bogen, KT; Hall, LC, 1989
)
0.7
"A unified physiologically based pharmacokinetic (PB-PK) model was developed and used to describe the disposition of methylchloroform (1,1,1-trichloroethane, MC) in three different species (rats, mice, and humans) after four different routes of exposure (inhalation, intravenous injection, bolus gavage, and drinking water administration)."( Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations.
Himmelstein, MW; McDougal, JN; Nolan, RJ; Reitz, RH; Schumann, AM, 1988
)
0.48
" The magnitude of the PK component of the interindividual variability factor (IVF; also referred to as human kinetic adjustment factor (HKAF)) has previously been estimated using Monte Carlo approaches and physiologically based pharmacokinetic (PBPK) models."( Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Krishnan, K; Nong, A, 2007
)
0.34

Bioavailability

ExcerptReferenceRelevance
"Due to the large surface area of the skin, percutaneous absorption has the potential to contribute significantly to the total bioavailability of some compounds."( Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans.
Corley, RA; Edwards, JA; Hui, X; Maibach, HI; Poet, TS; Thrall, KD; Weitz, KK; Wester, RC, 2000
)
0.31
" Such species-specific TDCT patterns may be jointly ascribed to temperature-mediated changes in (1) the physiological response and susceptibility of the marine ectotherms to the chemical, (2) speciation and bioavailability of the chemical, and (3) toxicokinetics of the chemical in the organisms."( Temperature-dependent toxicities of four common chemical pollutants to the marine medaka fish, copepod and rotifer.
Bao, VW; Leung, KM; Leung, PT; Li, AJ; Yi, AX, 2014
)
0.4
" An important aim of the study was to delineate and contrast the toxicokinetics (TK) and bioavailability (F) of TRI and its well metabolized congener, TCE."( Effect of dose and exposure protocol on the toxicokinetics and first-pass elimination of trichloroethylene and 1,1,1-trichloroethane.
Bruckner, JV; Cummings, BS; Hines, C; Mortuza, T; Muralidhara, S; White, CA, 2018
)
0.69

Dosage Studied

Study aimed to clarify whether dose-response profiles of acute behavioral effects of 1,2-dichloroethane differ. Rats dosed with 1,1,1-trichloraethane by gavage inhaled ambient air through the valve.

ExcerptRelevanceReference
" These permit the elaboration of dose-response lines for the substances in question, the calculation of median effective doses and the statistical analysis of differences in liver-damaging potency."( Quantitative aspects in the assessment of liver injury.
Plaa, GL, 1976
)
0.26
" A dose-response relationship was observed between the decrease in peak dp/dt and 1,1,1-TCE concentration."( Influence of heart rate on left ventricular dp/dt following 1,1,1-trichloroethane inhalation.
Hobara, T; Kawamoto, T; Kobayashi, H; Sakai, T; Tanaka, H,
)
0.37
" Moreover, a dose-response relationship was observed between the increase in respiratory rate and concentrations which exceeded the threshold level."( Respiratory disorders following 1,1,1-trichloroethane inhalation: a role of reflex mechanism arising from lungs.
Hobara, T; Kobayashi, H; Sakai, T; Satoh, T,
)
0.41
" Rats dosed with 1,1,1-trichloroethane by gavage inhaled ambient air through the valve."( A method for direct measurement of systemic uptake and elimination of volatile organics in small animals.
Bruckner, JV; Dallas, CE; Maedgen, JL; Weir, FW, 1986
)
0.61
" One of those TCE preparations caused effects at the high dosage level in terms of enhanced levels of the relation of liver to body weight; liver microsomal protein content; liver microsomal monooxygenase activity; and 3,4-dihydroxyphenylglycol excretion in urine."( Subacute toxicity of 1,1,1-trichloroethane, noise, and their combination in rats.
Blohm, M; Braun, H; Diehl, H; Jastorff, B; Kaschny, P; Schill, W, 1985
)
0.59
" A dose-response relationship between the decrease in perfusion pressure and 1,1,1-TCE concentration, which exceeded the threshold level, was observed."( Peripheral vasodilatation following 1,1,1-trichloroethane inhalation: peripheral vessels as a site of action.
Hobara, T; Kawamoto, T; Kobayashi, H; Sakai, T,
)
0.41
" Mutagenic effects were determined at several dosage levels for the two products and some of the identified components."( Mutagenicity in a modified Salmonella assay of fabric-protecting products containing 1,1,1-trichloroethane.
Bothwell, PD; Harrington, TR; Kowbel, DJ; Nestmann, ER; Otson, R, 1984
)
0.49
"5% in inspired air; moreover, a dose-response relationship between the decrease in blood pressure and 1,1,1-TCE concentration which exceeded the threshold level was observed."( Neural control of blood pressure following 1,1,1-trichloroethane inhalation: a role of sympathetic nervous system.
Hirota, H; Hobara, T; Kobayashi, H; Sakai, T,
)
0.39
"5 ml/kg; po), fasted 15 hr prior to dosing with 14C-TCEA (1."( Covalent binding of 14C-1,1,2-trichloroethane to hepatic proteins following acetone pretreatment.
Gandolfi, AJ; MacDonald, JR; Sipes, IG, 1982
)
0.26
" A control group with similar food restrictions was dosed with the same volume of water."( The pharmacokinetics of inhaled 1,1,1-trichloroethane following high milk intake in mice.
Dallas, CE; Muralidhara, S; You, L, 1994
)
0.57
" The dose-response relationship was investigated."( Effects of toluene, styrene, trichloroethylene, and trichloroethane on the vestibulo-and opto-oculo motor system in rats.
Eriksson, B; Larsby, B; Niklasson, M; Tham, R,
)
0.13
"5, 5, or 10 g TRI/kg po once daily for 5 consecutive days, rested for 2 days, and were dosed for 4 additional days."( Acute, short-term, and subchronic oral toxicity of 1,1,1-trichloroethane in rats.
Acosta, D; Bruckner, JV; Kyle, GM; Luthra, R; Mehta, SM; Muralidhara, S; Sethuraman, S, 2001
)
0.56
" Concentration-effect curves for diazepam and flurothyl were not altered by this modest regimen of repeated dosing with diazepam."( Evaluation of 1,1,1-trichloroethane and flurothyl locomotor effects following diazepam treatment in mice.
Balster, RL; Bühler, KG; Fagaldé, RE; LaVecchia, KL; Wiley, JL,
)
0.49
" Reduced body weights, decreased survival rates, and early mortality (in females) were found in mice dosed with 3000 or 6000 mg/kg day(- 1) (over the last 58 weeks; lower doses were administered for the first 20 weeks)."( Final report on the safety assessment of Trichloroethane.
, 2008
)
0.35
" Ultimately, careful control of dosing conditions (formulation, prandial state), and thus the extent of lymphatic transport, may be important in assuring reproducible efficacy and toxicity for lymphatically transported drugs."( The impact of lymphatic transport on the systemic disposition of lipophilic drugs.
Bulitta, JB; Caliph, SM; Cao, E; Han, S; Hu, L; Porter, CJ; Trevaskis, NL, 2013
)
0.39
" The experimental results showed that 1,1,1-TCA could be effectively degraded in 12 h for an initial Fe(0) dosage of 10 g L(-1) and a soil/water mass ratio of 1:5."( The reductive degradation of 1,1,1-trichloroethane by Fe(0) in a soil slurry system.
Du, X; Lin, K; Lu, S; Luo, Q; Qiu, Z; Sui, Q; Wu, X, 2014
)
0.69
"The present study aimed to clarify whether dose-response profiles of acute behavioral effects of 1,2-dichloroethane (DCE), 1,1,1-trichloroethane (TCE), trichloroethylene (TRIC), and tetrachloroethylene (PERC) differ."( Different behavioral effect dose-response profiles in mice exposed to two-carbon chlorinated hydrocarbons: influence of structural and physical properties.
Shibata, Y; Umezu, T, 2014
)
0.61
"51) among men in an analysis with 5 years lag-time, though without dose-response pattern."( Occupational solvent exposure and adult chronic lymphocytic leukemia: No risk in a population-based case-control study in four Nordic countries.
Auvinen, A; Hansen, J; Kjaerheim, K; Martinsen, JI; Pukkala, E; Talibov, M; Tryggvadottir, L; Weiderpass, E, 2017
)
0.46
" F did not vary significantly with TRI dose or dosage regimen."( Effect of dose and exposure protocol on the toxicokinetics and first-pass elimination of trichloroethylene and 1,1,1-trichloroethane.
Bruckner, JV; Cummings, BS; Hines, C; Mortuza, T; Muralidhara, S; White, CA, 2018
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
polar solventA solvent that is composed of polar molecules. Polar solvents can dissolve ionic compounds or ionisable covalent compounds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
chloroethanesA chloroalkane that is ethane in which one or more of the hydrogens is replaced by chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency1.77830.003245.467312,589.2998AID2517
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.79430.001318.074339.8107AID926; AID938
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency74.53910.001530.607315,848.9004AID1224841
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID603951In-vitro air to blood partition coefficients of the compound, logK(blood) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID37563Aneuploidy activity was determined; - indicates negative induction of aneuploidy in Aspergillus nidulans1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID603950In-vitro air to lung partition coefficients of the compound, logK(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID603952In-vitro blood to lung partition coefficients of the compound, logP(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID26047logBB, log(C brain / C blood)1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
Computation of brain-blood partitioning of organic solutes via free energy calculations.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (566)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990247 (43.64)18.7374
1990's98 (17.31)18.2507
2000's115 (20.32)29.6817
2010's87 (15.37)24.3611
2020's19 (3.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.30 (24.57)
Research Supply Index6.44 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index116.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (67.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.32%)5.53%
Reviews29 (4.66%)6.00%
Case Studies48 (7.72%)4.05%
Observational0 (0.00%)0.25%
Other543 (87.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]